Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Projected Valuation Of The Onychomycosis Treatment Market In The Coming Years?

In recent times, the market size for onychomycosis treatment has experienced significant growth. It is projected to escalate from $3.65 billion in 2024 to $3.91 billion in 2025, at a compound annual growth rate (CAGR) of 7.1%. The surge in growth during the previous period is attributed to factors such as a rise in fungal infections, an aging populace, increased public awareness, the growing frequency of onychomycosis, and a higher disposable income.

In the coming years, the market for onychomycosis treatment is slated to witness robust expansion. The market size is projected to scale up to $5.1 billion in 2029, growing at an impressive compound annual growth rate (CAGR) of 6.9%. This projected growth in the forecast period can be credited to several factors such as the growing elderly population, burgeoning telemedicine sector, advent of combination therapies, heightened access to healthcare, lifestyle changes, and environmental conditions that foster disease, as well as a rise in instances of diabetes. Key trends in the forecast period encompass developments in dermatology, innovations in drug delivery systems, the advent of customized treatment strategies, breakthroughs in topical treatments, digital health solutions, and advances in laser therapy.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12941&type=smp

What Drivers Are Accelerating Expansion Of The Onychomycosis Treatment Market?

The escalating prevalence of fungal infections is anticipated to boost the evolution of the onychomycosis treatment market. These infections, stemming from various fungi, can affect different sections of the body and lead to particular conditions. Onychomycosis, a type of fungal nail infection, is usually addressed with oral antifungal drugs or topical antifungal solutions to eradicate the source of fungal growth and promote the regeneration of healthy nails. For example, data from the UK Health Security Agency in September 2023 revealed that England experienced 2,265 bloodstream infection (BSI) instances, induced by yeast, as documented by the SGSS in 2022. The overall incidence of BSI due to yeast marked a minor increase to 4.0 per 100,000 population, a slight rise from 3.8 per 100,000 in 2021. The three yeast species most frequently found in blood samples were Candida albicans (40%), Nakaseomyces glabratus (previously Candida glabrata, 29%) and Candida parapsilosis (13%). Consequently, the surge in fungal infections is contributing to the expansion of the onychomycosis treatment market.

How Is The Global Onychomycosis Treatment Market Broken Down By Segment?

The onychomycosis treatmentmarket covered in this report is segmented –

1) By Type: Distal Sublingual Onychomycosis; White Superficial Onychomycosis; Proximal Sublingual Onychomycosis; Candida Onychomycosis; Other Types

2) By Treatment Type: Drugs; Laser Therapy; Photodynamic Therapy

3) By Age Group: 0 To 18 Years; 18 To 39 Years; 40 To 64 Years; 65 Years And Above

4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels

Which Market Trends Are Expected To Define The Future Of The Onychomycosis Treatment Market?

Prominent corporations in the onychomycosis treatment market are strategizing by creating novel products like MOB-015 and seeking their approval from government bodies to maintain their competitive advantage. Specifically, Moberg Pharma AB, a pharmaceutical company based in Sweden, obtained approval for MOB-015 in the European Union in June 2023, used for treating mild to severe nail fungal infections in adults. The European Union’s sanctioning of this innovative onychomycosis therapy represents its first worldwide marketing authorization. The endorsement of MOB-015 was supported by two Phase 3 trials that exhibited an enhanced mycological cure rate (76% vs. up to 42% for comparators) and a significantly higher total cure rate than the vehicle, all with zero severe side effects. The topical formulation of terbinafine, MOB-015, facilitates effective terbinafine concentrations to access the nail and nail bed while avoiding the systemic exposure risk tied to oral terbinafine treatment.

Which Firms Are Making The Biggest Impact In The Onychomycosis Treatment Market?

Major companies operating in the onychomycosis treatment market are Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Hetero Drugs Ltd., Sun Pharmaceutical Industries Limited, Cadila Pharmaceuticals Ltd., Dr. Reddys Laboratories Ltd., Intas Pharmaceuticals Limited, Cipla Limited, Lupin Limited, Glenmark Pharmaceuticals Ltd., Aurobindo Pharma Limited, Alkem Laboratories Limited, Jubilant Life Sciences Ltd., Torrent Pharmaceuticals Ltd., Mankind Pharma Ltd., Biocon Limited, Emcure Pharmaceuticals Limited, Alembic Pharmaceuticals Ltd., Laurus Labs Limited, Strides Pharma Science Limited, Aarti Drugs Ltd., NATCO Pharma Ltd., Unichem Laboratories Ltd., Indoco Remedies Ltd., Apex Laboratories Pvt. Ltd., Wockhardt Ltd., Nuray Chemicals Private Limited.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/onychomycosis-treatment-global-market-report

Which Geographic Regions Are Creating Strong Demand In The Onychomycosis Treatment Market?

North America was the largest region in the onychomycosis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in onychomycosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=12941&type=smp

Browse Through More Reports Similar to the Global Onychomycosis Treatment Market 2025, By The Business Research Company

Generic Pharmaceuticals Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/generic-pharmaceuticals-global-market-report

Ethical Pharmaceuticals Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ethical-pharmaceuticals-global-market-report

Biopharmaceuticals Contract Manufacturing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biopharmaceuticals-contract-manufacturing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model